← Alle mensen

AY

Alison Yan Zhang

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastati...
The Lancet. Oncology · 2025-03
Lu-PSMA-617 plus enzalutamide bij mCRPC: PSMAfore fase III
The Lancet. Oncology · 2024-05
OS met Lu-PSMA-617 versus cabazitaxel bij mCRPC: TheraP definitieve OS
The Lancet. Oncology · 2024-01